Ken Griffin Alpha Tau Medical Ltd. Transaction History
Citadel Advisors LLC
- $618 Billion
- Q3 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Citadel Advisors LLC holds 60,600 shares of DRTS stock, worth $224,826. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,600
Previous 66,479
8.84%
Holding current value
$224,826
Previous $207,000
31.88%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding DRTS
# of Institutions
37Shares Held
2.25MCall Options Held
0Put Options Held
0-
High Tower Advisors, LLC Chicago, IL687KShares$2.55 Million0.0% of portfolio
-
Hoyle Cohen, LLC269KShares$998,3160.05% of portfolio
-
Levin Capital Strategies, L.P. New York, NY205KShares$759,4880.09% of portfolio
-
Kovitz Investment Group Partners, LLC203KShares$753,9870.0% of portfolio
-
Mariner, LLC Overland Park, KS123KShares$457,2570.0% of portfolio
About Alpha Tau Medical Ltd.
- Ticker DRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,011,296
- Market Cap $256M
- Description
- Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...